Stockscreener 앱 받기
2.46
3.36%
0.08
시장 영업 전:
2.42
-0.04
-1.63%
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Microbot Medical Releases Updated Presentation Materials - TipRanks
Microbot Medical regains Nasdaq compliance with bid price - MSN
Microbot Medical bolsters leadership ahead of FDA decision By Investing.com - Investing.com South Africa
Microbot Medical® Bolsters Commercial Leadership Team with the A - GuruFocus
Microbot Medical (MBOT) Strengthens U.S. Leadership Ahead of FDA Decision | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Leadership Ahead of LIBERTY Launch - TipRanks
Microbot Medical bolsters leadership ahead of FDA decision - Investing.com
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers | MBOT Stock News - GuruFocus
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers - GlobeNewswire
Microbot Medical Accelerates FDA Launch Plans: Marketing VP with 15-Year Track Record Leads Commercial Push - Stock Titan
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
10 Best Rising Penny Stocks to Buy According to Analysts - Insider Monkey
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry - GlobeNewswire
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care Stocks Rise Wednesday Afternoon - TradingView
Sector Update: Health Care - marketscreener.com
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Stock Soars: Is the Rally Sustainable? - timothysykes.com
Microbot Medical Presents Successful Trial Results for LIBERTY System - TipRanks
Microbot Medical stock rises on trial win (MBOT:NASDAQ) - Seeking Alpha
Microbot Medical® Shares Results From Its Pivotal Clinical Trial - marketscreener.com
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic ... - Bluefield Daily Telegraph
Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire
Groundbreaking Clinical Trial: New Robotic System Cuts Surgeon Radiation by 92% - Stock Titan
3.24%
자본화:
|
볼륨(24시간):